Pratt Collard Advisory Partners’s Amgen AMGN Stock Holding History

Pratt Collard Advisory Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$393K	Buy	1,610 +580	+56%	+$143K	0.26%	76
2021 Q1	$256K	Buy	1,030 +30	+3%	+$7.16K	0.18%	88
2020 Q4	$230K	Sell	1,000 -5	-0.5%	-$1.15K	0.17%	91
2020 Q3	$255K	Hold	1,005	–	–	0.21%	85
2020 Q2	$237K	Buy	+1,005	New	+$229K	0.21%	84
2020 Q1	–	Sell	-935	Closed	-$225K	–	90
2019 Q4	$225K	Buy	+935	New	+$206K	0.17%	99
2019 Q1	–	Sell	-1,045	Closed	-$203K	–	110
2018 Q4	$203K	Hold	1,045	–	–	0.18%	96
2018 Q3	$217K	Buy	+1,045	New	+$206K	0.17%	105

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pratt Collard Advisory Partners's AMGN Position: Q2 2021 in Review

Pratt Collard Advisory Partners increased its Amgen (AMGN) stake by 56% in Q2 2021, buying an estimated $143K and bringing the position to 1,610 shares worth $393K. The position accounts for 0.26% of the portfolio, ranked #76.

Pratt Collard Advisory Partners first reported a position in AMGN in Q3 2018 and has held it in 8 quarters since. 2,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

Pratt Collard Advisory Partners held 1,610 shares of Amgen worth $393K as of Q2 2021.
Pratt Collard Advisory Partners bought 580 Amgen shares in Q2 2021, an estimated $143K.
Amgen made up 0.26% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #76 holding.
Pratt Collard Advisory Partners first reported a position in Amgen in Q3 2018 and has held it in 8 quarters since.
2,195 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.